BRIUMVI and pregnancy safety in multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at the effects of the MS medication BRIUMVI on pregnancy and baby health. It compares women who took BRIUMVI during pregnancy to those who did not.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have multiple sclerosis.
- You are currently pregnant or were pregnant within the last year.
- You have taken at least one dose of BRIUMVI, or you have not taken it at all during pregnancy.
- Your doctor allows your pregnancy data to be shared with the study.
- You have not taken other anti-CD20 medications during pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well BRIUMVI (a medicine for relapsing multiple sclerosis) works for people in everyday life. Researchers want to see how people do when they first start the medication.
This study collects information about pregnancies in people with multiple sclerosis (MS) who were exposed to Vumerity (diroximel fumarate) or who were not on MS medicines during pregnancy. It helps researchers understand pregnancy outcomes and safety in these situations.
This study looks at how certain multiple sclerosis medications (monoclonal antibodies) might affect the immune system of children whose mothers took them during pregnancy. It aims to understand if these treatments have any impact on the baby's developing immune system.
This study follows pregnant people with multiple sclerosis (MS) who took Mayzent (siponimod) to understand safety for pregnancy outcomes. It compares them with other groups to see whether there are any differences in birth results.
This study looks at the safety of Kesimpta (a multiple sclerosis medication) during pregnancy. It compares outcomes for women who took Kesimpta or other MS drugs while pregnant to those who did not.
This study tracks pregnant women with certain chronic health conditions (like multiple sclerosis, lupus, or rheumatoid arthritis) and healthy pregnant women as a comparison group. It aims to understand how these conditions and their treatments affect pregnancy, the baby, and breast milk.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.